BSE filing, NSE: ANKIN. Summary written from the filing by ALFA Finder's alert engine.
Anka India Ltd: key numbers
- Share price
- ₹19.10
- Market cap
- ₹98.45 Cr
- Revenue (annual)
- ₹18.09 Cr
- Net profit (annual)
- ₹-0.46 Cr
- P/E (TTM)
- -117.7×Sector 22.9×
- Promoter holding
- 87.14%-4.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anka India Ltd
All →Anka India Q2 FY27 Results: Net Loss of ₹0.3 Cr
Anka India Ltd reported revenue from operations of ₹1.6 Cr (-71.4% YoY) and a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Anka India Board Meeting Date
Anka India has scheduled a board meeting for 28 October 2026 to consider unaudited standalone and consolidated results for Q2 and H1 FY27. The trading window for insiders stays closed until 48 hours after results are declared.
Anka India Acquisition
Anka India Ltd received the NCLT order sanctioning the Scheme of Amalgamation of its wholly-owned subsidiary, Futech Internet Private Limited, with the company.
Anka India Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026. This disclosure details the current equity distribution among promoters and public shareholders.
Anka India Acquisition
Anka India Ltd received NCLT Chandigarh Bench approval for the Scheme of Amalgamation of its wholly-owned subsidiary, Futech Internet Private Limited, with the company.
Anka India Annual General Meeting
Anka India Ltd concluded its 32nd Annual General Meeting on September 30, 2026, through video conferencing to transact various ordinary and special business resolutions.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.